Annual Report 2011

Inspiring the Future.
Transforming research into reality.

Background Stories

Get more background on Actelion’s worldwide reach, new discovery projects and continuous commitment to PAH.



Learn more

Actelion today

Actelion is a biopharmaceutical company with four products on the market. We are proud to have one of the richest product pipelines among pharmaceutical companies of comparable size.
Our team of more than 2,500 committed professionals around the world is passionate about transforming innovation into new medicines.

Learn more

Business Strategy & Operations

2011 was a commercially successful year for Actelion despite the challenging macro-economic environment.

Learn more

Research & Development

Actelion has a broad and well-balanced pipeline with more than 15 compounds in development in various therapeutic indications.

Learn more

Corporate Governance

Actelion's Articles of Associoation, its By-Laws and its Policy on Ethical Conduct, all provide the basis for its principles of Corporate Governance.

Learn more

Corporate Social Responsibility

Actelion’s Corporate Responsibility reflects the company’s mission to provide innovative medicines for unmet medical needs in a responsible, respectful and ethical manner.

Learn more

Financial Report

Actelion achieved strong results with product sales of more than CHF 1.7 billon. However, these results were adversely affected by the ongoing economic crisis.

Learn more